Mood boosters reduce inflammation in IBD by 18%, study finds

New King’s College London research reveals that interventions which improve mood can reduce levels of inflammation in people with inflammatory bowel disease by 18 per cent, compared to having no mood intervention.

Future directions and challenges in harnessing NK cells against Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles

October 1, 2024

Zealand Pharma submits NDA for hyperinsulinism drug dasiglucagon

The NDA includes pivotal data from Phase III trials and a long-term extension, with one trial missing its primary endpoint. Credit: Shutterstock / Africa Studio.

July 3, 2023

Researchers create high-performing, eco-friendly sunscreen

In a significant breakthrough for the cosmetics industry, researchers have developed a new type of sunscreen using lignin, a naturally abundant polymer, and titanium dioxide

September 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.